Income Statement
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $30K | +81.8% | -1.9% |
| SG&A Expense | $59K | +106.9% | -42.5% |
| Operating Income | -$351K | -51.8% | +23.6% |
| Interest Expense | $46K | +27.3% | -31.1% |
| Pre-tax Income | -$444K | -41.5% | +16.3% |
| Income Tax | -$24K | -51.9% | — |
| Net Income | -$419K | -40.9% | +20.5% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
Balance Sheet
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $34K | -64.4% | -45.4% |
| Total Assets | $44K | -57.7% | -40.2% |
| Current Liabilities | $5.8M | +1.7% | -32.6% |
| Long-term Debt | $0 | -100.0% | — |
| Total Liabilities | $5.8M | +1.7% | -32.6% |
| Stockholders' Equity | -$2.9M | -5.7% | +48.9% |
Cash Flow
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$607K | — | — |
| Capital Expenditures | $3K | — | — |
| Investing Cash Flow | -$3K | — | — |
| Financing Cash Flow | $590K | — | — |
| Free Cash Flow | -$610K | — | — |